Search results
FDA approves bladder cancer treatment by Culver City company
LA Times via Yahoo News· 3 days agoThe Food and Drug Administration has approved Culver City-based ImmunityBio's treatment for bladder ...
Gilead Notches A Quarterly Beat On The Back Of Its Covid Drug, Again
Investor's Business Daily· 9 minutes agoTecartus treats forms of lymphoma and leukemia, while Trodelvy is a breast and bladder cancer ...
FDA Approves New Bladder Cancer Drug
Medscape· 3 days agoThe first-in-class agent is approved alongside bacillus Calmette-Guérin to treat certain non–muscle-invasive bladder cancers that do not respond to...
ImmunityBio Inc. Drug Approved By FDA
The Post-Journal· 14 hours agoOn Monday, the Food and Drug Administration officially approved ANKTIVA, a treatment for unresponsive non-muscle invasive bladder cancer
FDA approves immunotherapy drug combo for non-muscle invasive bladder cancer
Medical Xpress· 2 days agoChamie, who was the principal investigator for the trial, reported that this combination treatment...
Young breast cancer survivors almost twice as likely to develop another cancer, study finds
The Telegraph via Yahoo News· 15 hours agoParticular risks were found for lung, kidney, head and neck, bladder, esophageal and stomach cancers...
FDA Approves ImmunityBio's Bladder Cancer Drug, Stock Rallies
Benzinga via Yahoo Finance· 2 days agoThe drug is combined with the BCG vaccine, mainly used against tuberculosis and as a common ...
King Charles’ Funeral Plans Dusted Off, as His Health Remains a Mystery
The Daily Beast via Yahoo News· 9 hours agoPhoto Illustration by Luis G. Rendon/The Daily Beast/Getty ImagesIt’s the question everyone in...
Recurrence Data for Narrow Band Imaging™ (NBI™) Technology Show Value in the Fight Against...
KLAS Las Vegas· 1 day ago"Without dyes, without any change to the patient's standard cystoscopy, and with only a push of a button, urologists can better visualize a lesion, and potentially contribute to reduced recurrence ...
ImmunityBio stock jumps as FDA clears bladder cancer therapy (NASDAQ:IBRX)
Seeking Alpha· 2 days agoShares of ImmunityBio (IBRX) surged 33% premarket after FDA clearance of its combination therapy for...
